可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Pomerantz BJ, Joo K, Shames BD, et al. Adenosine preconditioning reduces both prepostischemias in human myocardium[J]. J Surg Res, 2000, 90(2):191-196.[2] Butler KL, Huffman LC, Koch SE, et al. STAT3 activation is necessary for ischemic preconditioning in hypertrophied myocardium[J]. Am J Physiol Heart Circ Physiol, 2006, 291(2):H797-H803.[3] Rajesh KG, Sasaguri S, Suzuki R, et al. Ischimic preconditioning prevents reperfusion heart injury in cardiac hypertrophy by activation of mitochondrial tolerance to experimental calcium overload[J]. Cardio Res, 2002, 103(2):438-455.[4] Hattori R, Maulik N, Otani H, et al. Role of STAT3 in ischemic preconditioning[J]. J Mol Cell Cardiol, 2001, 33(11):1929-1936.[5] Sharma A, Singh M. Possible mechanism of cardioprotective effect of angiotensin preconditioning in isolated rat heart[J]. Eur J Pharmacol, 2000, 406(1):85-92.[6] Sommerschild HT, Kirkeboen KA. Preconditioningendogenous defence mechanisms of the heart[J]. Acta Anaesthesiol Scand , 2002, 46(2):123-137.[7] Demoulin JB, Van Roost E, Stevens M, et al. Distinct roles for STAT1, STAT3 and STAT5 indifferentiation gene induction and apoptosis inhibition by interleukin9[J]. Biol Chem, 1999, 274(36):25855-25861.[8] Smith RM, Suleman N, Lacerda L, et al. Genetic depletion of cardiacmyocyte STAT3 abolishes classical precondition[J]. Cardiovasc Res, 2004, 63(4):611-616.[9] Kranzhofer R, Schmidt J, Pfeiffer CA, et al. Angiotensin induces inflammatory activation of human vascular smooth muscle cells[J]. Arterioscler Thromb Vasc Biol, 1999, 19(7):1623-1629.